| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-01-31 10:08 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+99,000 vol |
99,000 | |
| Filed 2024-01-31 10:08 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 10:08 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+201,000 vol |
201,000 | |
| Filed 2024-01-31 10:07 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Tennyson, Anthony
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:33 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+73,700 vol |
73,700 | |
| Filed 2024-01-31 08:33 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:32 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+36,300 vol |
36,300 | |
| Filed 2024-01-31 08:32 Tx date 2021-12-14 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Carter, Paul Rutherford
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:29 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+107,200 vol |
107,200 | |
| Filed 2024-01-31 08:28 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-31 08:28 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+52,800 vol |
52,800 | |
| Filed 2024-01-31 08:28 Tx date 2021-06-28 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Nutt, David John
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:55 Tx date 2024-01-30 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
56 - Grant of rights
|
+99,000 vol |
99,000 | |
| Filed 2024-01-30 15:55 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:54 Tx date 2024-01-30 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
56 - Grant of rights
|
+201,000 vol |
201,000 | |
| Filed 2024-01-30 15:53 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Held, Jonathan James
5 - Senior Officer of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:21 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
DSU
50 - Grant of options
|
+36,300 vol |
36,300 | |
| Filed 2024-01-30 15:20 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
DSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-30 15:20 Tx date 2024-01-26 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
RSU
50 - Grant of options
|
+73,700 vol |
73,700 | |
| Filed 2024-01-30 15:20 Tx date 2021-06-16 |
$AWKN
Awakn Life Sciences Corp. (1169082 BC Ltd.) |
Page, Stephen Robert
4 - Director of Issuer
Direct Ownership
|
RSU
00 - Opening Balance-Initial SEDI Report
|